OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro
Dan Wang, Cheng Lu, Jieru Li, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 167, pp. 106009-106009
Closed Access | Times Cited: 12
Dan Wang, Cheng Lu, Jieru Li, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 167, pp. 106009-106009
Closed Access | Times Cited: 12
Showing 12 citing articles:
The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking
Wen Zhu, Yehui Li, Junjie Zhao, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 541-552
Open Access | Times Cited: 55
Wen Zhu, Yehui Li, Junjie Zhao, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 541-552
Open Access | Times Cited: 55
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 27
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 27
Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium
Dandan Liu, Chaoyang Zhang, Jingting Zhang, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106250-106250
Open Access | Times Cited: 18
Dandan Liu, Chaoyang Zhang, Jingting Zhang, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106250-106250
Open Access | Times Cited: 18
Iterative Optimization Yields Stapled Peptides with Superior Pharmacokinetics and Potency for Renal Fibrosis Treatment
Bochuan Deng, Ping Su, Cheng Lu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Bochuan Deng, Ping Su, Cheng Lu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis
Dan Wang, Bochuan Deng, Lü Cheng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 722-738
Open Access | Times Cited: 15
Dan Wang, Bochuan Deng, Lü Cheng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 722-738
Open Access | Times Cited: 15
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
Zhibin Yan, Xurui Cheng, Tao Wang, et al.
Genes & Diseases (2022) Vol. 9, Iss. 6, pp. 1493-1505
Open Access | Times Cited: 13
Zhibin Yan, Xurui Cheng, Tao Wang, et al.
Genes & Diseases (2022) Vol. 9, Iss. 6, pp. 1493-1505
Open Access | Times Cited: 13
Peptide mediated therapy in fibrosis: Mechanisms, advances and prospects
Xun Ye, Jinhu Li, Zibo Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113978-113978
Open Access | Times Cited: 11
Xun Ye, Jinhu Li, Zibo Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113978-113978
Open Access | Times Cited: 11
Potential role of biopeptides in the treatment of idiopathic pulmonary fibrosis
Shraddha Karande, Kalicharan Sharma, Anoop Kumar, et al.
Health Sciences Review (2023) Vol. 6, pp. 100081-100081
Open Access | Times Cited: 4
Shraddha Karande, Kalicharan Sharma, Anoop Kumar, et al.
Health Sciences Review (2023) Vol. 6, pp. 100081-100081
Open Access | Times Cited: 4
Effect of Pheretima aspergillum on reducing fibrosis: A systematic review and meta-analysis
Tianren Xu, Xiaonan Liu, Shengguang Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Tianren Xu, Xiaonan Liu, Shengguang Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
DR7dA, a Novel Antioxidant Peptide Analog, Demonstrates Antifibrotic Activity in Pulmonary Fibrosis In Vivo and In Vitro
Lu Cheng, Dan Wang, Bochuan Deng, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 382, Iss. 2, pp. 100-112
Open Access | Times Cited: 5
Lu Cheng, Dan Wang, Bochuan Deng, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 382, Iss. 2, pp. 100-112
Open Access | Times Cited: 5
The novel peptide DR4penA attenuates the bleomycin‐ and paraquat‐induced pulmonary fibrosis by suppressing the TGF ‐β/Smad signaling pathway
Dan Wang, Bochuan Deng, Lu Cheng, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 2
Dan Wang, Bochuan Deng, Lu Cheng, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 2
The peptide DR3penA exhibits antifibrotic activity in multiple pulmonary fibrosis models induced by particulate and soluble chemical fibrogenic agents
Jieru Li, Bochuan Deng, Jiao Zhang, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 2, pp. 701-714
Open Access | Times Cited: 2
Jieru Li, Bochuan Deng, Jiao Zhang, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 2, pp. 701-714
Open Access | Times Cited: 2
